Apelin-related biomedical research
Apelin-related biomedical research is a research topic within Pharmacology. Science Explorer counts 11k research works in it since 1950. 18.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of apelin, a novel adipokine, and its receptor APJ in various physiological processes such as cardiovascular regulation, angiogenesis, obesity, diabetes, and neuroprotection. The research covers molecular properties, tissue distribution, signaling pathways, therapeutic potential, and pathophysiological implications of the apelin/APJ system.
- Apelin
- APJ Receptor
- Cardiovascular
- Angiogenesis
- Obesity
- Diabetes
- Hypertension
- Neuroprotective
- Adipokine
- G Protein-Coupled Receptor
- Research works
- 11k fractional, since 1950
- In the world top 10%
- 2k per year above
- Top-10% rate
- 18.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Apelin-related biomedical research research?
By volume, China and the United States publish the most (400 and 290 works in 2022–2025).
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Apelin-related biomedical research research?
By volume in 2022–2025, University of Baghdad publishes the most Apelin-related biomedical research research, followed by Cairo University and Kharkiv National Medical University.
By volume, 2022–2025
- 1 University of BaghdadIraq 12 works
- 2 Cairo UniversityEgypt 8 works
- 3 Kharkiv National Medical UniversityUkraine 8 works
- 4 Zagazig UniversityEgypt 8 works
- 5 Ain Shams UniversityEgypt 8 works
- 6 Medical University of WarsawPoland 8 works
- 7 InsermFrance 7 works
- 8 Central South UniversityChina 7 works
- 9 University of South ChinaChina 6 works
- 10 Sağlık Bilimleri ÜniversitesiTürkiye 6 works
Where is Apelin-related biomedical research research done?
The largest centres of Apelin-related biomedical research research in 2022–2025 are Beijing (China), Shanghai (China), Baghdad (Iraq) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Baghdad.
Largest cities, 2022–2025
Where it is the local speciality
- BaghdadIQ · 26.6 works7.0×
Location quotient: how much more of its research is in Apelin-related biomedical research than the world average.
Where is the best place to study Apelin-related biomedical research?
Among universities, judged by research, Cairo University and University of Baghdad score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Cairo UniversityEgypt | 55.0 | 7.8% | 5.8× | 8 | +215.2% |
| 2 | University of BaghdadIraq | 45.0 | 0.7% | 8.6× | 12 | +9.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Apelin-related biomedical research research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Apelin-related biomedical research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.